21.01.2017 | Rebuttal Letter
Response to “Do metastasis-free interval less or more than 24 months for recurrent metastatic breast cancer and primary surgery for de novo metastatic breast cancer matter for survival?”
Erschienen in: Breast Cancer Research and Treatment | Ausgabe 2/2017
Einloggen, um Zugang zu erhalten